China Resources Medical Holdings Company Limited (1515.HK) stock price, financials & research

Regular session · HKT · Market data may be delayed.

Company profile

Operating as an investment holding firm, China Resources Medical Holdings Company Limited delivers a spectrum of healthcare services, encompassing general medical care, hospital administration, and advisory functions within the People's Republic of China. Its business activities are structured into three main divisions: hospitals it directly owns, facilities managed under Invest-Operate-Transfer (IOT) or Operate-Transfer (OT) agreements, and other ancillary operations. The company further provides group purchasing solutions and various services derived from its hospital network. A key component of its strategy involves managing and operating external hospitals and clinics through its IOT model. Additionally, the enterprise is active in the sale of pharmaceuticals, medical apparatus, medical consumables, and specialized equipment. Established in 2007, the company adopted its current name, China Resources Medical Holdings Company Limited, in October 2018, having previously been known as China Resources Phoenix Healthcare Holdings Company Limited. Its corporate headquarters are located in Beijing, People's Republic of China.

Industry: Medical - Care Facilities
Sector: Healthcare
Headquarters: CN
CEO: Chuang Zhang
Listed since: Nov 29, 2013
Employees: 19,687

Market position

Day range

Current HK$2.60

HK$2.59HK$2.645

52-week range

Current HK$2.60

HK$2.34HK$3.90

Open: HK$2.61
Previous close: HK$2.61
Volume: 596K; 0.27× average
Average volume: 2.18M; Average daily volume
Market cap: 3.29B HKD
Beta: 0.57; Market reference 1
50-day average: HK$2.5124; +3.49% above average
200-day average: HK$2.9063; -10.54% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 3.49B CNY
P/E (TTM): 5.71×
P/B (TTM): 0.44×
P/S (TTM): 0.31×
EV / EBITDA: 3.69×
Earnings yield: 13.53%
Free cash flow yield: 23.03%
Dividend yield: 5.82%

Profitability & efficiency

Gross margin: 15.70%
Operating margin: 4.60%
Net margin: 5.41%
Return on equity: 7.57%
Return on assets: 3.84%
Return on invested capital: 3.42%

Financial health

Debt / equity: 0.13×
Current ratio: 0.64×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

9.18B CNY-6.89%

Operating income

422.51M CNY-45.48%

Net income

495.94M CNY-12.36%

Metric (CNY)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	9.18B CNY	9.85B CNY	10.11B CNY	7.9B CNY	4.45B CNY
Cost of goods sold	7.73B CNY	8.04B CNY	8.2B CNY	4.65B CNY	3.51B CNY
Gross profit	1.44B CNY	1.81B CNY	1.91B CNY	1.31B CNY	933.56M CNY
Selling, general, and administrative	1.02B CNY	1.05B CNY	973.5M CNY	828.19M CNY	488.23M CNY
Operating expenses	1.02B CNY	1.03B CNY	1.05B CNY	776.31M CNY	565.88M CNY
Interest income	10.18M CNY	14.21M CNY	68.36M CNY	93.35M CNY	77.45M CNY
Interest expense	48.28M CNY	61.01M CNY	114.86M CNY	55.9M CNY	16.23M CNY
Depreciation and amortization	524.06M CNY	559.11M CNY	610.86M CNY	486.41M CNY	160.23M CNY
Operating income	422.51M CNY	774.98M CNY	852.42M CNY	441.54M CNY	367.68M CNY
Net income	495.94M CNY	565.88M CNY	257.68M CNY	265.86M CNY	417.92M CNY